Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
13 May 2024 | Story Carmenita Redcliffe-Paul
Global Citizen

The University of the Free State (UFS) and the South African Chamber of Commerce United Kingdom (SACC UK) are pleased to present a Global Citizen Series conversation, Exploring Scenarios: South Africa’s Democracy in the face of the next general elections, from the perspective of Clem Sunter, international best-selling author, futurologist, and scenario planner. 

As part of the Global Citizen Webinar Series, international scenario planner and futurologist, Clem Sunter, will join UFS Vice-Chancellor and Principal, Prof Francis Petersen, and SACC UK Chairperson, Sharon Constançon, for a conversation that answers the question – What does the future hold for South Africa’s democracy in the face of the upcoming general elections?

Thirty years ago, the majority of South Africans won the right to vote for the first time, leading to South Africa’s first democratic elections in 1994. Join us for a conversation on 20 May 2024 as we explore scenarios depicted by Clem Sunter ahead of South Africa’s seventh general elections scheduled for 29 May 2024.

Join the Global conversation for Global Citizens

Date:  Monday, 20 May 2024
SA time: 15:00-16:00 / UK time: 14:00-15:00
The livestream link will be shared with those who RSVP
Enquiries: Tebello Leputla - leputlatb@ufs.ac.za +27 51 401 9199

About Clem Sunter

Clem Sunter, born in Suffolk England on 8 August 1944, gained his education at Winchester College. Before joining Charter Consolidated as a management trainee in 1966, he went to Oxford where he read politics, philosophy, and economics.

He moved to Lusaka in Zambia to work for the Anglo-American Corporation Central Africa in 1971. He then transferred to the head office of the Anglo-American Corporation of South Africa in Johannesburg in 1973. He spent most of his succeeding career in the Gold and Uranium Division, where he served as chairman and CEO from 1990 to 1996. During this time, Anglo-American was the largest producer of gold in the world. Until recently he was chairman of the Anglo-American Chairman’s Fund, which was – as stated in a recent survey – the primary corporate social responsibility fund in South Africa. Read more about Clem Sunter.

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept